4//SEC Filing
ORiordan Anne 4
Accession 0001765581-23-000098
CIK 0001232524other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:51 PM ET
Size
6.9 KB
Accession
0001765581-23-000098
Insider Transaction Report
Form 4
ORiordan Anne
Director
Transactions
- Award
Ordinary Shares
2023-08-11+3,075→ 13,792 total - Sale
Ordinary Shares
2023-08-14$138.16/sh−1,241$171,454→ 12,551 total
Footnotes (3)
- [F1]Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.67 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001767870
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 7:51 PM ET
- Size
- 6.9 KB